Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic diarrhea: therapy with antibiotics].

T M Bauer1

  • 1Abteilung Innere Medizin II, Medizinische Universitätsklinik Freiburg.

Praxis
|November 18, 2000
PubMed
Summary

Chronic diarrhoea in developed nations often stems from non-infectious causes. Antibiotic treatment for diarrhoea should typically follow microbiological diagnosis, except in specific cases like traveller's diarrhoea.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lorlatinib versus crizotinib as first-line treatment for advanced ALK-positive non-small-cell lung cancer: 7-year update from the phase III CROWN study.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer<sup>☆</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Area of Science:

  • Gastroenterology
  • Microbiology
  • Internal Medicine

Context:

  • Chronic diarrhoea is a common condition in developed countries.
  • Most cases are attributed to organic or functional disorders, not infections.
  • Infectious causes are infrequent but important to consider.

Purpose:

  • To review the role of microbiological diagnosis in managing chronic diarrhoea.
  • To discuss the indications for empirical antibiotic treatment.

Summary:

  • Chronic diarrhoea is predominantly caused by non-infectious disorders in developed countries.
  • Microbiological diagnosis is generally recommended before antibiotic therapy.
  • Empirical antibiotics may be used for persistent traveller's diarrhoea or small intestinal bacterial overgrowth.

Impact:

  • Guides clinical practice on appropriate diagnostic and treatment strategies for chronic diarrhoea.
  • Emphasizes the importance of evidence-based antibiotic use in gastroenterology.
  • Reduces unnecessary antibiotic prescriptions, potentially mitigating antimicrobial resistance.

Related Experiment Videos